中化合成生技股份有限公司
中化合成生醫科技股份有限公司（Chunghwa Chemical Synthesis & Biotech Co., Ltd.）為中化集團旗下的原料藥（API）專業製造廠，具備美國 FDA 的 cGMP 認證。公司專精於化學合成與微生物發酵兩大技術，提供包括免疫抑制劑、心血管疾病藥物、抗真菌藥物及肌肉鬆弛劑等之活性醫藥原料，主要產品外銷至美、日等國際學名藥廠。公司成立於 1964 年，總部位於台灣新北市。
該股 RSI(6) 為 36.9，處於中性區間，短線無明顯超買超賣訊號。股價跌破5日、20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=43.0）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -3 | 0 | 0 | -3 |
| 09-23 | 0 | 0 | 0 | 0 |
| 09-22 | +8 | 0 | 0 | +8 |
| 09-21 | +4 | 0 | 0 | +4 |
| 09-18 | +21 | 0 | +5 | +26 |
| 09-17 | +22 | 0 | +1 | +23 |
| 09-16 | -6 | 0 | 0 | -6 |
| 09-15 | -11 | 0 | +2 | -9 |
| 09-14 | -10 | 0 | 0 | -10 |
| 09-11 | -34 | 0 | -4 | -38 |
| 09-10 | -6 | 0 | +2 | -4 |
| 09-09 | -83 | 0 | -2 | -85 |
| 09-08 | -34 | 0 | -1 | -35 |
| 09-07 | -51 | 0 | +3 | -48 |
| 09-04 | -26 | 0 | +1 | -25 |
| 09-03 | -35 | 0 | 0 | -35 |
| 09-02 | +84 | 0 | -4 | +80 |
| 09-01 | -3 | 0 | -1 | -4 |
| 08-31 | -11 | 0 | -1 | -12 |
| 08-28 | -23 | 0 | +1 | -22 |
| 08-27 | -28 | 0 | +1 | -27 |
| 08-26 | +6 | 0 | +5 | +11 |
| 08-25 | -1 | 0 | 0 | -1 |
| 08-24 | -48 | 0 | 0 | -48 |
| 08-21 | +75 | 0 | +1 | +76 |
| 08-20 | +130 | 0 | 0 | +130 |
| 08-19 | -7 | 0 | 0 | -7 |
| 08-18 | -2 | 0 | 0 | -2 |
| 08-17 | +29 | 0 | +1 | +30 |
| 08-14 | +12 | 0 | -9 | +3 |
| 08-13 | -15 | 0 | -3 | -18 |
| 08-12 | -41 | 0 | +4 | -37 |
| 08-11 | +39 | 0 | -1 | +38 |
| 08-10 | -91 | 0 | +6 | -85 |
| 08-07 | +175 | 0 | -5 | +170 |
| 08-06 | +17 | 0 | -4 | +13 |
| 08-05 | +30 | 0 | -10 | +20 |
| 08-04 | -6 | 0 | -9 | -15 |
| 08-03 | +36 | 0 | -24 | +12 |
| 07-31 | -49 | 0 | +28 | -21 |
| 07-30 | +32 | 0 | +5 | +37 |
| 07-29 | -44 | 0 | +6 | -38 |
| 07-28 | +58 | 0 | -9 | +49 |
| 07-27 | -17 | 0 | +2 | -15 |
| 07-24 | +5 | 0 | -1 | +4 |
| 07-23 | -63 | 0 | -4 | -67 |
| 07-22 | -51 | 0 | +2 | -49 |
| 07-21 | -21 | 0 | -2 | -23 |
| 07-20 | -43 | 0 | +13 | -30 |
| 07-17 | -165 | 0 | +1 | -164 |
| 07-16 | -91 | 0 | +2 | -89 |
| 07-15 | +14 | 0 | -1 | +13 |
| 07-14 | -60 | 0 | +3 | -57 |
| 07-13 | -85 | 0 | -8 | -93 |
| 07-09 | -169 | 0 | 0 | -169 |
| 07-08 | -41 | 0 | 0 | -41 |
| 07-07 | +323 | 0 | -8 | +315 |
| 07-06 | +327 | 0 | +12 | +339 |
| 07-03 | +85 | 0 | -2 | +83 |
| 07-02 | -28 | 0 | +1 | -27 |
| 07-01 | +7 | 0 | 0 | +7 |
| 06-30 | +2 | 0 | -3 | -1 |
| 06-29 | +20 | 0 | 0 | +20 |
| 06-26 | -69 | 0 | +3 | -66 |
| 06-25 | +4 | 0 | +3 | +7 |
| 06-24 | +24 | 0 | -8 | +16 |
| 06-22 | +84 | 0 | +1 | +85 |
| 06-18 | +43 | 0 | +3 | +46 |
| 06-17 | +29 | 0 | -2 | +27 |
| 06-16 | -154 | 0 | -1 | -155 |
| 06-15 | -1 | 0 | +2 | +1 |
| 06-12 | -170 | 0 | -1 | -171 |
| 06-10 | -75 | 0 | +6 | -69 |
| 06-09 | -43 | 0 | -2 | -45 |
| 06-08 | -30 | 0 | -24 | -54 |
| 06-03 | +86 | 0 | +2 | +88 |
| 06-02 | +16 | 0 | +3 | +19 |
| 06-01 | +60 | 0 | -2 | +58 |
| 05-29 | -193 | 0 | 0 | -193 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/08 | 5910 萬 | -34.2% | +30.3% |
| 2026/07 | 8977 萬 | -11.8% | +23.2% |
| 2026/06 | 1.02 億 | +40.5% | -40.2% |
| 2026/05 | 7243 萬 | -44.7% | -27.2% |
| 2026/04 | 1.31 億 | -0.3% | +76.0% |
| 2026/03 | 1.31 億 | +27.8% | +108.8% |
| 2026/02 | 1.03 億 | -18.9% | +161.3% |
| 2026/01 | 1.27 億 | +119.1% | +40.0% |
| 2025/12 | 5792 萬 | +38.0% | -45.2% |
| 2025/11 | 4195 萬 | +209.7% | -59.5% |
| 2025/10 | 1354 萬 | -62.7% | -82.4% |
| 2025/09 | 3627 萬 | - | -70.7% |